| Tyyppi : |
Lehti |
| Internet-yhteys : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4526 |
|
| Tutkimus Joukkueet : |
Rochester - Wegmans School of Pharmacy |
| Tekijät : |
Zhao F, Dave V.S, Mar M, Perri J. |
| Otsikko : |
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding. |
| Numero : |
Int J Pharm Compound 22,5:433-439 2018 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Eslicarbazepine acetate
|
 |
 |
 |
 |
1200 mg
Aptiom® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
2-8°C |
 |
| 63 |
 |
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
2-8°C |
|
| 63 |
|
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
25°C |
|
| 63 |
|
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
25°C |
|
| 63 |
|
|
|
|
|
